首页> 外文期刊>Prostate International >Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
【24h】

Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer

机译:高风险前列腺癌患者自由基前列腺切除术后的条件生化复发术

获取原文
       

摘要

BackgroundConditional survival?is defined as the likelihood of subsequent survival given the precondition of having already survived a certain length of time. Most analyses of conditional survival in prostate cancer?are not clinically applicable because they do not analyze outcomes conditioned on the durability of cure after treatment. We evaluated the conditional probability of biochemical recurrence (BCR)-free survival (C-BCRFS) after radical prostatectomy (RP) for prostate cancer according to the National Comprehensive Cancer Network risk classification and prognostic factors in patients who survived several years without BCR.MethodsBetween January 2009 and December 2018, 877 patients with complete clinicopathologic and follow-up data were included. Using the Kaplan–Meier estimation, the probabilities of C-BCRFS after RP were estimated in patients who did not experience BCR at 0–4?years. C-BCRFS was analyzed according to the National Comprehensive Cancer Network risk classification and compared using the log-rank test. Prognostic factors at each year without BCR were evaluated using multivariable Cox regression analysis.ResultsThe median follow-up duration and patient age were 48?months and 67?years, respectively. As the BCR-free interval increased (baseline, 1, 2, 3, and 4?years after RP), the 5-year C-BCRFS rates improved marginally (74.8%, 83.2%, 89.1%, 93.6%, and 98.5%, respectively). However, the 5-year C-BCRFS rates in the high/very high-risk group rose from 54.0% at baseline to 67.6%, 80.3%, 88.6, and 97.8% after 1–4?years free of BCR, respectively. In patients with a BCR-free duration more than 1?year, only seminal vesicle invasion and pathological Gleason score were significant predictive factors of BCR thereafter.ConclusionIn the high/very high-risk group, the C-BCRFS markedly improved as the interval without BCR increased. In patients who were BCR-free for several years, seminal vesicle invasion and pathological Gleason score were prognostic factors of continued BCRFS. This is useful not only for patient counseling but also to optimize postoperative follow-up strategies.
机译:背景可持续生存?被定义为后续生存的可能性给出了已经在一定时间内幸存下来的前提。大多数分析前列腺癌中的条件存活?在临床上不是临床应用,因为它们没有分析治疗后治疗耐久性的结果。根据国家综合癌症网络风险分类和预后因素,在没有BCR的情况下,我们评估了在激进前列腺切除术(RP)后前列腺癌(RP)的生物化学复发(BCR) - 免疫存活(C-BCRF)的条件概率。 2009年1月和2018年12月,包括877名患有完整的临床病理和后续数据的患者。使用Kaplan-Meier估计,RP后C-BCRFS的概率估计在0-4岁的患者中没有经历BCR的患者中。根据国家综合癌症网络风险分类进行分析C-BCRFS,并使用日志排名测试进行比较。使用多变量Cox回归分析评估每年的预后因素。培养中间的后续持续时间和患者年龄分别为48个月和67岁。随着BCR的间隔增加(基线,1,2,3和4年后RP岁月),5年的C-BCRFS率略微改善(74.8%,83.2%,89.1%,93.6%和98.5% , 分别)。然而,在1-4年内,高/非常高风险群体的5年的C-BCRFS率在基线上的54.0%上升至67.6%,80.3%,88.6和97.8%,分别是免费的BCR。在不含BCR的持续时间的患者中,只有精囊侵袭和病理肠胃酵法评分的显着预测因子,其后是高/非常高风险的群体,C-BCRF在没有的间隔内显着改善BCR增加。在不含BCR的患者中,最初的囊泡侵袭和病理肠胃逝分是持续的BCRF的预后因素。这不仅适用于患者咨询,而且是优化术后随访策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号